Overall Status

Completed (1)

Terminated (1)

Withdrawn (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

National Cancer Institute (NCI) (1)

Vanderbilt-Ingram Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

Study Documents

Intervention Type

other (3)

biological (2)

drug (1)

radiation (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

recurrent merkel cell carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma AJCC v7, Stage IIIA Merkel Cell Carcinoma AJCC v7 Trial in

Completed

Has Results

Recurrent Merkel Cell Carcinoma
+4 more

Laboratory Biomarker Analysis
Pembrolizumab

Palo Alto, California
+12 more

Mar 17, 2022

Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

Withdrawn

Functional Pancreatic Neuroendocrine Tumor
+28 more

Capecitabine
+4 more

(no location specified)

Sep 26, 2017

Recurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma Trial in Seattle (biological, other, radiation)

Terminated

Recurrent Merkel Cell Carcinoma
Stage IV Merkel Cell Carcinoma

Aldesleukin
+4 more

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

Apr 17, 2017